You are here

Therapeutic areas [br]& products

The Biocodex story started modestly, bringing Saccharomyces boulardii

CNCM I-745® to market in France as a therapeutic brand named ULTRA-LEVURE®.

This single celled, non-pathogenic yeast therapeutic has since become the world’s number one yeast-based probiotic in the world.  

From this scientific and commercial success, Biocodex has built its worldwide company into a diverse pharmaceutical organization with an international portfolio of products.

Today, Biocodex specializes in the following therapeutic areas:

English
Sub title: 
Meaningful solutions to<br/>challenging healthcare problems
Ordre : 
2
Conclusion: 

Additional licensed products through our subsidiaries.

User login